• Latest Posts

German Biotech Enters the Clinic with Next-Generation Antibody for AML

Swiss Biotech raises €9M to Treat Sudden Hearing Loss in Phase III

Swiss Researchers get to the Genetic Bottom of Kidney Cancer

“Trust me, I’m an Artist” Explores the Ethics of Biotech in Amsterdam

UPDATE: UK Cannabis Biotech ready for a Blockbuster in Rare Epilepsy

Resilient Tumor Cells Drive Breast Cancer Relapse in Mice

ADVERTISEMENT

UK biotech is catching up to the US, but will it run out of gas?

French Biotech Enters New Agreement to Advance its IBD Immunotherapy

Curious about Who is Living in Your Gut? This Kit Can Tell You

German Biotech Tops Up its Oncolytic Virus with Immuno-Oncology Drugs

Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic

Norwegian Biotech Goes for Combination Therapies in Melanoma

ADVERTISEMENT